Amendment in Export Policy of Remdesivir Injection and API

Amendment in Export Policy of Remdesivir Injection and API

Amendment in Export Policy of Remdesivir Injection and API, Amphotericin-B Injections, Enoxaparin (Formulation and API) and Intra-Venous Immunoglobulin (IVIG) (Formulation and API) – Notification No. 56/2015-20

Read More on DGFT

Post Views: 664

CA Cult

SEBI – Companies paid royalty exceeding 20% of net profits

SEBI – Companies paid royalty exceeding 20% of net profits

Harmonisation of Schedule-II (Export Policy), ITC(HS) 2022

Harmonisation of Schedule-II (Export Policy), ITC(HS) 2022

Fixation of new SIONs under ‘Chemical and Allied Product’

Fixation of new SIONs under ‘Chemical and Allied Product’

Advisory on IMS on the Supplier View

Advisory on IMS on the Supplier View

Advisory regarding IMS during initial phase of its implementation

Advisory regarding IMS during initial phase of its implementation

Trading supported by Blocked Amount in the Secondary Market

Trading supported by Blocked Amount in the Secondary Market